Reducing the burden of coronary artery disease in India: Challenges and opportunities

Indian Heart Journal

Volumn 60, Issue 2, 2008, Pages 161-175

  Enas, Enas A ^a   Singh, Vibhuti ^b   Munjal, Y P ^c,d   Bhandari, Suman ^d,e   Yadave, Ram Dev ^f   Manchanda, S C ^a  

^a Coronary Artery Disease in Asian Indians ^*  (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Indian College of Physicians

^d Escorts Heart Institute and Research Centre ^*

^e Batra Hospital India   (India)

^f ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Coronary artery disease; Guidelines; Health Summit; Primary prevention

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN A; TRIACYLGLYCEROL; WARFARIN;

ABDOMINAL OBESITY; ARTICLE; ASIA; BRAIN HEMORRHAGE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIET; DYSLIPIDEMIA; EPIDEMIC; EXERCISE; FOOD INTAKE; FRUIT; GENETIC PREDISPOSITION; GOVERNMENT; HEALTH CARE; HEALTH PROGRAM; HUMAN; INDIA; LIFESTYLE; METABOLIC SYNDROME X; RISK FACTOR; RURAL AREA; SITTING; SMOKING; URBAN AREA; VEGETABLE;

ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; CORONARY ARTERY DISEASE; HUMANS; INDIA; LIFE STYLE; MASS SCREENING; MOTOR ACTIVITY; PRACTICE GUIDELINES AS TOPIC; PRIMARY PREVENTION; RISK FACTORS;

EID: 48749120952     PISSN: 00194832     EISSN: 00194832     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Enas EA. How to Beat the Heart Disease Epidemic among South Asians: a Prevention and Management Guide for Asian Indians and their Doctors. Downers Grove: Advanced Heart Lipid Clinic USA, 2007.
2. Singh V, Deedwania P. Dyslipidemia in special populations: Asian Indians, African Americans, and Hispanics. Curr Atheroscler Rep 2006;8:32?40.
3. Enas EA. Coronary artery disease epidemic in Indians: a cause for alarm and call for action. J Indian Med Assoc 2000;98:694?695, 697?702.
4. Enas EA, Yusuf S, Mehta J. Meeting of International Working Group on coronary artery disease in South Asians. Indian Heart J 1996;48:727?732.
5. World Health Organization. Preventing Chronic Disease: A Vital Investment World Heath Organization, Geneva 2005.
6. Indrayan A. Forecasting vascular disease cases and associated mortality in India 2007; http://www.whoindia.org/LinkFiles/ Commision_on_Macroeconomic_and_Health_Bg_P2_Forecasting_vascular_disease_ cases_and_associated_mortality_in_India.pdf: Accessed November 6, 2007.
7. American Heart Association Heart and Stroke Statistical Update, 2008. http://www.americanheart.org/downloadable/heart/200078608862HS_Stats%202008. final.pdf
8. Reddy KS. India wakes up to the threat of cardiovascular diseases. J Am Coll Cardiol 2007;50:370?372.
9. Joshi P, Islam S, Pais P, et al. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA 2007;297:286?294.
10. Enas EA, Chacko V, Pazhoor SG, Chennikkara H, Devarapalli HP. Dyslipidemia in South Asian patients. Curr Atheroscler Rep 2007;9:367?374.
11. Deedwania P, Singh V. Coronary artery disease in South Asians: evolving strategies for treatment and prevention. Indian Heart J 2005;57:617?631.
12. Superko HR, Enas EA, Kotha P, Bhat NK, Garrett B. High-density lipoprotein subclass distribution in individuals of Asian Indian descent: The National Asian Indian Heart Disease Project. Prev Cardiol 2005;8:81?86.
13. Bhalodkar NC, Blum S, Rana T, Bhalodkar A, Kitchappa R, Enas EA. Effect of leisure time exercise on high-density lipoprotein cholesterol, its subclasses, and size in asian indians. Am J Cardiol 2005;96:98?100.
14. Dodani S, Kaur R, Reddy S, Reed GL, Mohammad N. Can dysfunctional HDL explain high coronary artery disease risk in South Asians? Int J Cardiol 2008.
15. Enas EA. Indian diet and cardiovascular disease: an update. In: Chatterjee SS, ed. Update in Cardiology Hyderabad: Cardiology Society of India, 2007.
16. Enas EA, Mohan V, Deepa M, Farooq S, Pazhoor S, Chennikkara H. The metabolic syndrome and dyslipidemia among Asian Indians: a population with high rates of diabetes and premature coronary artery disease. J Cardiometab Syndr 2007;2:267?275.
17. Chaturvedi N, Fuller JH. Ethnic differences in mortality from cardiovascular disease in the UK: do they persist in people with diabetes? J Epidemiol Community Health 1996;50:137?139.
18. Chaturvedi N, Jarrett J, Morrish N, Keen H, Fuller JH. Differences in mortality and morbidity in African Caribbean and European people with non-insulin dependent diabetes mellitus: results of 20 year follow up of a London cohort of a multinational study. BMJ 1996;313:848?852.
19. Singh VN. Metabolic syndrome: an evolving clinical challenge. PICOMESO February 2006;45:3,12.
20. Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs Framingham risk score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 2005;165:2644?2650.
21. Whincup PH, Gilg JA, Papacosta O, et al. Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children. BMJ 2002;324:635.
22. Miller GJ, Beckles GL, Maude GH, et al. Ethnicity and other characteristics predictive of coronary heart disease in a developing community: principal results of the St James Survey, Trinidad. Int J Epidemiol 1989;18:808?817.
23. Forouhi NG, Sattar N, Tillin T, McKeigue PM, Chaturvedi N. Do known risk factors explain the higher coronary heart disease mortality in South Asian compared with European men? Prospective follow-up of the Southall and Brent studies, UK. Diabetologia 2006;49:2580?2588.
24. Enas EA, Chacko V, Senthilkumar A, Puthumana N, Mohan V. Elevated Lipoprotein(a) - A genetic risk factor for premature vascular disease in people with and without standard risk factors: A Review. Dis Mon 2006;52:5?50.
25. Gambhir JK, Kaur H, Gambhir DS, Prabhu KM. Lipoprotein(a) as an independent risk factor for coronary artery disease in patients below 40 years of age. Indian Heart J 2000;52:411?415.
26. Christopher R, Kailasanatha KM, Nagaraja D, Tripathi M. Case-control study of serum lipoprotein(a) and apolipoproteins A-I and B in stroke in the young. Acta Neurol Scand 1996;94:127?130.
27. Enas EA. Why Indians are more susceptible to Coronary artery disease: role of specific risk factors In: Chatterjee SS, ed. Update in Cardiology Hyderabad: Cardiology Society of India, 2007.
28. Enas EA, Senthilkumar A, Chacko V, Puthumana N. Dyslipidemia among Indo-Asians: strategies for identification and management. Brit J Diabetes Vascular Dis 2005;5:81?90.
29. Enas EA, Jacob S. Decline of CAD in developed countries: lessons for India. In: Sethi K, ed. Coronary Artery Disease in Indians - A Global Perspective. Mumbai: Cardiological Society of India, 1998:98?113.
30. Beaglehole R, Ebrahim S, Reddy S, Voute J, Leeder S. Prevention of chronic diseases: a call to action. Lancet 2008;370:2152-2157.
31. Epping-Jordan JE, Galea G, Tukuitonga C, Beaglehole R. Preventing chronic diseases: taking stepwise action. Lancet 2005;366:1667?1671.
32. Rose G. The strategy of preventive medicine. New York: Oxford University Press, 1992:1?135.
33. Pais PS. Early intervention and prevention of myocardial infarction. J Hypertens Suppl 2006;24:S25?S30.
34. Enas EA, Yusuf S, Sharma S. Coronary artery disease in South Asians; Second meeting of the International Working Group, 16 March 1997, Anaheim, California. Indian Heart J 1998;50:105?13.
35. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388?2398.
36. Murray CJ, Lauer JA, Hutubessy RC, et al. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 2003;361:717?725.
37. O'Keefe JH Jr, Cordain L, Harris WH, Moe RM, Vogel R. Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal. J Am Coll Cardiol 2004;43:2142?2146.
38. NCEP III. Third Report of the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III): National Institute of Health, 2002.
39. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157?163.
40. Snehalatha C, Viswanathan V, Ramachandran A. Cutoff values for normal anthropometric variables in Asian Indian adults. Diabetes Care 2003;26:1380?1384.
41. Grundy SM, Pasternak R, Greenland P, Smith S, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 1999;100:1481?1492.
42. Lip GY, Barnett AH, Bradbury A, et al. Ethnicity and cardiovascular disease prevention in the United Kingdom: a practical approach to management. J Hum Hypertens 2007;21:183?211.
43. D'Agostino RB, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001;286:180?187.
44. Graham I, Atar D, Borch-Johnsen K, Boysen G, Durrington PN. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J 2007;28:2375?2414.
45. Bhopal R, Fischbacher C, Vartiainen E, Unwin N, White M, Alberti G. Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to Newcastle Heart Project data. J Public Health (Oxf) 2005;27:93?100.
46. Quirke TP, Gill PS, Mant JW, Allan TF. The applicability of the Framingham coronary heart disease prediction function to black and minority ethnic groups in the UK. Heart 2003;89:785?786.
47. Aarabi M, Jackson PR. Predicting coronary risk in UK South Asians: an adjustment method for Framingham-based tools. Eur J Cardiovasc Prev Rehabil 2005;12:46?51.
48. Rosendorff C, Black HR, Cannon CP, et al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 2007;115:2761?2788.
49. Lopez V A, Franklin SS, Tang S, Wong ND. Coronary heart disease events preventable by control of blood pressure and lipids in US adults with hypertension. J Clin Hypertens (Greenwich) 2007;9:436?443.
50. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227?239.
51. Mohan V, Sandeep S, Deepa M, Gokulakrishnan K, Datta M, Deepa R. A diabetes risk score helps identify metabolic syndrome and cardiovascular risk in Indians - the Chennai Urban Rural Epidemiology Study (CURES-38). Diabetes Obes Metab 2007;9:337?343.
52. Mosca L, Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol 2007;49:1230?1250.
53. Liu J, Sempos C, Donahue RP, Dorn J, Trevisan M, Grundy SM. Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. Diabetes Care 2005;28:1916?1921.
54. Lu W, Resnick HE, Jablonski KA, et al. Non-HDL Cholesterol as a Predictor of Cardiovascular Disease in Type 2 Diabetes: The Strong Heart Study. Diabetes Care 2003;26:16?23.
55. Stein EA. Statins and children: whom do we treat and when? Circulation 2007;116:594?595.
56. McCrindle BW, Urbina EM, Dennison BA, et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation 2007;115:1948-1967.
57. Shen AY, Yao JF, Brar SS, Jorgensen MB, Chen W. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol 2007;50:309?315.
58. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007;297:842?857.
59. Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006;113:2363?2372.
60. Singh VN. Need for more aggressive statin use in various ethnic groups - Latinos, Asian Indians, and African Americans. eMEDICINE Feature Series - LIPID Newsletter. October 20, 2005.
61. Deedwania PC, Singh VN. Coronary Artery Disease in South Asians: Evolving Strategies For Treatment and Prevention. Indian Heart J 2005;57:617?631.
62. Ridker PM, Fonseca FA, Genest J et al. Baseline characteristics of participants in the JUPITER Trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity c-reactive protein. Am J Cardiol 2007;100:1659?1664.